Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$237M |
| 2 |
AbbVie
ABBV
|
+$190M |
| 3 |
FedEx
FDX
|
+$149M |
| 4 |
Sysco
SYY
|
+$133M |
| 5 |
Coca-Cola
KO
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$306M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
Union Pacific
UNP
|
+$193M |
| 4 |
Walmart Inc
WMT
|
+$185M |
| 5 |
Alibaba
BABA
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.17% |
| 2 | Financials | 11.79% |
| 3 | Technology | 11.07% |
| 4 | Consumer Staples | 10.39% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Supernus Pharmaceuticals
SUPN
$2.65B
| $1.75M | ﹤0.01% |
125,100
+10,100
| +9% | +$188K |
|
2077
Bristow Group
VTOL
$1.32B
| $1.75M | ﹤0.01% |
+58,600
| New | +$2.03M |
|
2078
QuidelOrtho
QDEL
$1.13B
| $1.75M | ﹤0.01% |
92,700
+24,113
| +35% | +$516K |
|
2079
Crocs
CROX
$6.14B
| $1.75M | ﹤0.01% |
+135,094
| New | +$1.96M |
|
2080
Luxfer Holdings
LXFR
$455M
| $1.75M | ﹤0.01% |
161,800
-711
| -0.4% | -$8.77K |
|
|
MSON
2081
DELISTED
Misonix Inc
MSON
| $1.75M | ﹤0.01% |
162,697
+23,000
| +16% | +$228K |
|
|
GWB
2082
DELISTED
Great Western Bancorp, Inc.
GWB
| $1.75M | ﹤0.01% |
68,800
-177,253
| -72% | -$4.46M |
|
|
ALDW
2083
DELISTED
Alon USA Partners LP
ALDW
| $1.74M | ﹤0.01% |
+74,800
| New | +$1.77M |
|
2084
Crown Crafts
CRWS
$31.7M
| $1.74M | ﹤0.01% |
212,300
+17,700
| +9% | +$143K |
|
|
COVS
2085
DELISTED
Covisint Corporation
COVS
| $1.74M | ﹤0.01% |
809,000
-206,408
| -20% | -$568K |
|
2086
Timberland Bancorp
TSBK
$349M
| $1.74M | ﹤0.01% |
159,600
+4,700
| +3% | +$49.9K |
|
2087
State Street Utilities Select Sector SPDR ETF
XLU
$23B
| $1.74M | ﹤0.01% |
80,200
+65,600
| +449% | +$1.41M |
|
2088
Global Net Lease
GNL
$1.86B
| $1.73M | ﹤0.01% |
+62,833
| New | +$1.61M |
|
|
RC
2089
Ready Capital
RC
$261M
| $1.73M | ﹤0.01% |
129,416
+4,567
| +4% | +$70.1K |
|
|
SEM
2090
DELISTED
Select Medical
SEM
| $1.73M | ﹤0.01% |
+297,558
| New | +$2.21M |
|
2091
Green Brick Partners
GRBK
$3.02B
| $1.73M | ﹤0.01% |
159,635
-142,742
| -47% | -$1.72M |
|
|
INTX
2092
DELISTED
Intersections, Inc.
INTX
| $1.72M | ﹤0.01% |
828,800
+25,800
| +3% | +$57.3K |
|
|
HIL
2093
DELISTED
Hill International, Inc. Common Stock
HIL
| $1.72M | ﹤0.01% |
524,800
+87,304
| +20% | +$384K |
|
|
LSG
2094
DELISTED
LAKE SHORE GOLD CORP
LSG
| $1.72M | ﹤0.01% |
2,068,398
-1,150,000
| -36% | -$987K |
|
2095
Daktronics
DAKT
$941M
| $1.72M | ﹤0.01% |
197,900
-5,700
| -3% | -$58.5K |
|
2096
Coherus Oncology
CHRS
$227M
| $1.71M | ﹤0.01% |
85,500
+44,593
| +109% | +$1.36M |
|
|
WRI
2097
DELISTED
Weingarten Realty Investors
WRI
| $1.71M | ﹤0.01% |
51,600
+5,200
| +11% | +$174K |
|
2098
Anika Therapeutics
ANIK
$242M
| $1.71M | ﹤0.01% |
53,600
-63,600
| -54% | -$2.22M |
|
|
GEN
2099
DELISTED
Genesis Healthcare, Inc.
GEN
| $1.7M | ﹤0.01% |
277,600
+23,700
| +9% | +$161K |
|
2100
Corcept Therapeutics
CORT
$12.8B
| $1.7M | ﹤0.01% |
452,200
-49,414
| -10% | -$251K |
|
Similar funds
Renaissance Technologies's Q3 2015 Portfolio in Review
As of Q3 2015, Renaissance Technologies held 3,649 positions worth $41.9B, down 4.5% from $43.9B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
Renaissance Technologies deployed $1.51B of net new capital in Q3 2015, opening 454 new positions and adding to 1,731 existing holdings. Its largest new stake was FedEx: 936,400 shares worth $135M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Walmart Inc, an estimated $185M trimmed.
- Renaissance Technologies's largest Q3 2015 buy was FedEx: 936,400 shares worth $135M.
- Renaissance Technologies added most to SIGMA - ALDRICH CORP in Q3 2015, an estimated $237M increase.
- Renaissance Technologies's biggest Q3 2015 reduction was Walmart Inc, cutting an estimated $185M.
- Renaissance Technologies fully exited Microsoft in Q3 2015, selling an estimated $306M.
- Renaissance Technologies's ten largest holdings make up 9.9% of its $41.9B portfolio in Q3 2015.
- Renaissance Technologies opened 454 new positions and closed 519 in Q3 2015.
- Renaissance Technologies's portfolio value fell 4.5% quarter-over-quarter to $41.9B.
Based on Renaissance Technologies's 13F filing for Q3 2015, filed 12 Nov 2015.